Thermo Fisher Scientific

#CorEvitas #Mergers and acquisitions #Real world data #Thermo Fisher Scientific

Thermo Fisher Scientific acquires real-world evidence provider

Thermo Fisher Scientific has completed its acquisition of CorEvitas, a provider of real-world evidence for approved medical treatments and therapies, for $912.5 million. Real-world evidence is a high growth market segment as pharmaceutical and biotechnology customers, as well as regulating bodies, are increasingly looking to monitor and evaluate the safety… Read More

#Business & Investment #News

#Data #Data security #Database #Thermo Fisher Scientific

New listicle: Three data problems solved by a connected lab

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More

#News

#Data #Data security #Database #Thermo Fisher Scientific

Listicle: Three data problems solved by a connected lab

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More

#Listicles #Videos

Lipid nanoparticle mRNA vaccine
#In Focus Report #mRNA #mRNA-based vaccines #Thermo Fisher Scientific

In depth eReport – mRNA: New uses for this exciting technology

Although the concept of messenger ribonucleic acid (mRNA) as a potential therapeutic technology has been around for decades, it took a global pandemic to give the mRNA platform the necessary shot in the arm and development has proceeded at astonishing speed since. Download this In Focus eReport… Read More

#News

#In Focus Report #mRNA #mRNA-based vaccines #Thermo Fisher Scientific

mRNA: New uses for this exciting technology

Download this In Focus eReport to gain a full understanding of the current market for mRNA vaccines and therapeutics and the areas of greatest commercial potential for the future. The eReport includes: In-depth analysis of regional markets An overview of the likely challenges and opportunities The companies taking the lead… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Drug development #Drug discovery #eBook #Imaging #Thermo Fisher Scientific

New handbook: Your guide to imaging success

A new eBook entitled the ‘Imaging protocol handbook’, brought to you by Thermo Fisher Scientific, is now available to download. This guide will provide you with: A quick and easy way to find the most used and trusted protocols for imaging A go‑to resource for reliable methods… Read More

#News

#Drug development #Drug discovery #Imaging #Thermo Fisher Scientific

Imaging protocol handbook

This guide will provide you with: A quick and easy way to find the most used and trusted protocols for imaging A go‑to resource for reliable methods Step‑by‑step methods to enable your imaging success… Read More

#Resources

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

New listicle: Five tips on scaling up IVT for mRNA production

The success of messenger RNA or mRNA vaccines in the fight against the global SARS-CoV-2 crisis brings a new era of vaccine development. In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. By partnering… Read More

#Editor's Choice #News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

Listicle: Five tips on scaling up IVT for mRNA production

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More

#Listicles #Videos

#Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #Rare disease #Rare Disease Day #Thermo Fisher Scientific

Unlocking the potential of mRNA for the future treatment of rare diseases 

mRNA technology helped us to vaccinate the world against SARS-CoV-2. As we turn our focus to new potential applications and disease areas for the platform, scientists and companies must consider the potential life-saving impact on rare, inherited diseases, says Archana Gupta, PhD, staff scientist in genetic sciences at Thermo Fisher… Read More

#Exclusive Content #Opinion

#High throughput screening #Lab automation #Thermo Fisher Scientific

Sample handling system relieves sample processing bottleneck  

Thermo Fisher Scientific has launched a new automated sample transfer system that can process 192 saliva or nasopharyngeal samples from tube to well in 40 minutes to address a pain point and accelerate sample processing workflow.   The ‘pain point’  Scientific research in areas such as… Read More

#News

#Bioban #Biologics #Covid-19 #Life sciences #Thermo Fisher Scientific

Reforming biobanks: from siloes to collaborative powerhouses

By Erik Steinfelder, Biobanking Market Development Director at Thermo Fisher Scientific From hidden repositories, secreted deep in the basements of universities and hospitals, to the emergence of collaborative powerhouses driving ground-breaking therapies, biobanks have come a long way in the past 30 years. Biobanks were originally created as vast repositories… Read More

#Covid-19 #Exclusive Content #News